CL2009001747A1 - Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales. - Google Patents

Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales.

Info

Publication number
CL2009001747A1
CL2009001747A1 CL2009001747A CL2009001747A CL2009001747A1 CL 2009001747 A1 CL2009001747 A1 CL 2009001747A1 CL 2009001747 A CL2009001747 A CL 2009001747A CL 2009001747 A CL2009001747 A CL 2009001747A CL 2009001747 A1 CL2009001747 A1 CL 2009001747A1
Authority
CL
Chile
Prior art keywords
eugenol
xylitol
excipients
preparation
pharmaceutical composition
Prior art date
Application number
CL2009001747A
Other languages
English (en)
Inventor
González Tomás Bernardo Galván
Original Assignee
Galvan Gonzalez Tomas Bernardo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galvan Gonzalez Tomas Bernardo filed Critical Galvan Gonzalez Tomas Bernardo
Priority to CL2009001747A priority Critical patent/CL2009001747A1/es
Priority to PT108094145T priority patent/PT2510916T/pt
Priority to BR112012003842-7A priority patent/BR112012003842B1/pt
Priority to CN2010800434354A priority patent/CN102639100A/zh
Priority to PCT/CL2010/000030 priority patent/WO2011020206A1/es
Priority to ES10809414.5T priority patent/ES2632363T3/es
Priority to US13/391,334 priority patent/US8865136B2/en
Priority to DK10809414.5T priority patent/DK2510916T3/en
Priority to RU2012110038/15A priority patent/RU2558061C2/ru
Priority to EP10809414.5A priority patent/EP2510916B1/en
Publication of CL2009001747A1 publication Critical patent/CL2009001747A1/es
Priority to IN2053DEN2012 priority patent/IN2012DN02053A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA COMPOSICIÓN FARMACÉUTICA ANTISÉPTICA, QUE COMPRENDE:<br /> 0,05 Y 0,3% P/P DE PERÓXIDO DE HIDRÓGENO O SU EQUIVALENCIA EN PERÓXIDO DE CARBAMIDA;<br /> 0,001 Y 0,03% P/P DE EUGENOL;<br /> 0,001 Y 0,01% P/P DE ALCANFOR;<br /> 0,001 Y 0,5% P/P DE UNA SAL DE ZINC U OTROS METALES PESADOS COMO PLATA, MERCURIO, COBRE O ESTAÑO<br /> O MEZCLA DE LOS MISMOS;<br /> 1 A 1,2% P/P DE FLUORURO DE SODIO;<br /> 2% A 7% P/P DE XILITOL; Y<br /> EXCIPIENTES EN CANTIDAD SUFICIENTE PARA ENTERAR 100% DE LA COMPOSICIÓN TOTAL; MÉTODO DE PREPARACIÓN DE LA<br /> MISMA; Y SU USO PARA PREVENIR Y/O TRATAR ENFERMEDADES ORALES.<br />  
CL2009001747A 2009-08-20 2009-08-20 Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales. CL2009001747A1 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CL2009001747A CL2009001747A1 (es) 2009-08-20 2009-08-20 Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales.
ES10809414.5T ES2632363T3 (es) 2009-08-20 2010-08-19 Composición farmacéutica antiséptica para la higiene bucal y el tratamiento de enfermedades bucales de origen microbiano
BR112012003842-7A BR112012003842B1 (pt) 2009-08-20 2010-08-19 Composição antisséptica, método de formulação e uso da mesma
CN2010800434354A CN102639100A (zh) 2009-08-20 2010-08-19 用于口腔卫生和治疗微生物起源的口腔疾病的抗菌药物组合物
PCT/CL2010/000030 WO2011020206A1 (es) 2009-08-20 2010-08-19 Composición farmacéutica antiséptica útil para la higiene bucal y el tratamiento de las enfermedades orales de origen microbiano
PT108094145T PT2510916T (pt) 2009-08-20 2010-08-19 Composição farmacêutica antisséptica para a higiene oral e o tratamento de doenças bucais de origem microbiana
US13/391,334 US8865136B2 (en) 2009-08-20 2010-08-19 Antiseptic pharmaceutical composition for oral hygiene and the treatment of oral diseases of microbial origin
DK10809414.5T DK2510916T3 (en) 2009-08-20 2010-08-19 ANTISEPTIC PHARMACEUTICAL COMPOSITION FOR ORAL HYGIENE AND THE TREATMENT OF ORAL DISEASES OF MICROBIAL ORIGIN
RU2012110038/15A RU2558061C2 (ru) 2009-08-20 2010-08-19 Антисептическая фармацевтическая композиция для гигиены полости рта и лечения заболеваний полости рта микробного происхождения
EP10809414.5A EP2510916B1 (en) 2009-08-20 2010-08-19 Antiseptic pharmaceutical composition for oral hygiene and the treatment of oral diseases of microbial origin
IN2053DEN2012 IN2012DN02053A (es) 2009-08-20 2012-03-07

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2009001747A CL2009001747A1 (es) 2009-08-20 2009-08-20 Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales.

Publications (1)

Publication Number Publication Date
CL2009001747A1 true CL2009001747A1 (es) 2010-09-10

Family

ID=43606512

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001747A CL2009001747A1 (es) 2009-08-20 2009-08-20 Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales.

Country Status (11)

Country Link
US (1) US8865136B2 (es)
EP (1) EP2510916B1 (es)
CN (1) CN102639100A (es)
BR (1) BR112012003842B1 (es)
CL (1) CL2009001747A1 (es)
DK (1) DK2510916T3 (es)
ES (1) ES2632363T3 (es)
IN (1) IN2012DN02053A (es)
PT (1) PT2510916T (es)
RU (1) RU2558061C2 (es)
WO (1) WO2011020206A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140294742A1 (en) * 2011-10-10 2014-10-02 Ul Tradent Products, Inc. Anti-plaque dental compositions
EP2957282B1 (en) * 2013-02-07 2021-04-14 Tomás Bernardo Galván González Oral antiseptic composition for treating oral mucositis
CH707698A1 (de) 2013-03-12 2014-09-15 Bonyf Ag Pharmazeutisches Mittel zur Behandlung von Schleimhautentzündungen.
US20160228339A1 (en) 2013-09-18 2016-08-11 Glymur B.V. Oral hygiene compositions
BR112017007638B1 (pt) * 2014-10-23 2021-02-02 Colgate-Palmolive Company composições de higiene bucal que compreendem compostos de zinco e compostos de peróxido
RU2600443C1 (ru) * 2015-07-17 2016-10-20 Леонид Борисович Потёмкин Лечебно-профилактическая зубная паста
CN105327337A (zh) * 2015-10-30 2016-02-17 中国人民解放军96617部队 抗辐射防龋消炎口腔制剂
CN107441020B (zh) * 2017-08-14 2020-09-29 武汉美一棠口腔有限公司 种植牙术后保养液及种植牙术后保养方法
JP2018048155A (ja) * 2017-10-05 2018-03-29 ゴンザレス トマス ベルナルド ガルヴァン 口腔粘膜炎を治療するための口腔殺菌性組成物
WO2019084255A1 (en) * 2017-10-26 2019-05-02 Reynoso Bernardino BUCCO-DENTAL CARE COMPOSITIONS AND METHODS OF USE
CN108126128A (zh) * 2018-02-02 2018-06-08 上海哈美实业发展有限公司 一种口腔抗菌凝胶剂及其制备方法
US20210260107A1 (en) * 2018-06-25 2021-08-26 Triumph Pharmaceuticals Inc. Methods Of Inhibiting Microbial Infections Using Zinc-Containing Compositions
US12156927B2 (en) 2019-06-24 2024-12-03 Gpq S.R.L. Formulation for odontological and dermatological use containing trchloroacetate salts and hydroxyacids
WO2021001986A1 (ja) * 2019-07-04 2021-01-07 株式会社ソーシン 動物用の口腔用組成物並びにそれを使用した動物用の歯周病予防剤、感染症予防剤及び口臭予防剤
CA3152752A1 (en) 2019-10-01 2021-04-08 Thomas Henley Genetic engineering of fungi to modulate tryptamine expression
BR102019021197A2 (pt) * 2019-10-09 2021-04-20 Luiz Jabbur Junior agente de gargarejo compreendendo um conjunto de substâncias acopladas, método de uso e controle do caseum
US12083209B2 (en) 2020-02-18 2024-09-10 Sunstar Americas, Inc. Oral care composition
US11638722B2 (en) * 2020-03-25 2023-05-02 Therapeutica Borealis Oy C/O Avance Attorneys Ltd. Medicine for Covid-19 and treatment
WO2022066444A1 (en) * 2020-09-24 2022-03-31 Medline Industries, Lp Oral rinse composition, oral cleansing kit, method of cleansing oral cavity and method of making oral rinse composition
EP4204101A1 (en) * 2020-11-09 2023-07-05 Colgate-Palmolive Company Oral care compositions and preservative systems
CN117999056A (zh) * 2021-07-02 2024-05-07 真点科学有限公司 预防和/或治疗口腔中牙齿周围软组织和硬组织的疾病的口服药物组合物
CN118984868A (zh) 2021-12-31 2024-11-19 恩派瑞安神经科学公司 用于产生精神药物生物碱的遗传修饰的生物体

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387647A1 (fr) * 1977-04-20 1978-11-17 Spad Lab Pate de traitement endodontique pour l'obturation canalaire de dents
US4226851A (en) * 1979-07-11 1980-10-07 Sompayrac Hewitt A Stable dental composition containing hydrogen peroxide
US4436721A (en) * 1983-06-08 1984-03-13 Colgate-Palmolive Company Oral composition having mole ratio of tetra (methylene phosphonate) to alkali metal fluoride of at least 1.4:1
GB8411841D0 (en) 1984-05-09 1984-06-13 Unilever Plc Oral compositions
US5104644A (en) 1990-02-07 1992-04-14 7-L Corporation Mouthrinse composition
US5174990A (en) * 1990-02-07 1992-12-29 7-L Corporation Mouthrinse and method of preparation
WO1997026855A1 (en) * 1996-01-24 1997-07-31 Warner-Lambert Company Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems
WO2000000166A2 (en) * 1998-06-29 2000-01-06 Warner-Lambert Company Improved oral compositions for control and prevention of tartar, oral malodor, plaque and gingivitis
US6723305B2 (en) * 2002-03-04 2004-04-20 Colgate Palmolive Company Anti-microbial breath freshening mouthrinse
US6689342B1 (en) * 2002-07-29 2004-02-10 Warner-Lambert Company Oral care compositions comprising tropolone compounds and essential oils and methods of using the same
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
US20060045854A1 (en) * 2004-08-27 2006-03-02 Lynette Zaidel Oral care composition with cross-linked polymer peroxide
US20060140882A1 (en) * 2004-12-29 2006-06-29 Tambs Gary E Two phase whitening oral care composition
BRPI0502145A (pt) * 2005-06-03 2007-01-23 Mauricio Duarte Da Conceicao enxaguatório para prevenção e tratamento da halitose
US20090191510A1 (en) * 2005-06-22 2009-07-30 Cao Group, Inc. Periodontal treatment employing applied ultrasonic energy
US8337819B2 (en) * 2005-06-28 2012-12-25 Tomas Bernardo Galvan Pharmaceutical composition for the oral hygiene, the treatment of the periodontal illnesses and the halitosis
US8241681B2 (en) * 2005-10-14 2012-08-14 Symrise Ag Synergistic mixtures of bisabolol and ginger extract
CN101389223A (zh) * 2006-02-24 2009-03-18 吉百利亚当斯美国有限责任公司 填充液体的咀嚼型胶基糖组合物
ES2462925T3 (es) * 2006-06-14 2014-05-26 Symrise Ag Compuestos con efecto antimicrobiano para el tratamiento de fetidez oral

Also Published As

Publication number Publication date
US20120148506A1 (en) 2012-06-14
BR112012003842B1 (pt) 2023-11-28
EP2510916A1 (en) 2012-10-17
EP2510916B1 (en) 2017-04-05
RU2558061C2 (ru) 2015-07-27
US8865136B2 (en) 2014-10-21
IN2012DN02053A (es) 2015-08-21
ES2632363T3 (es) 2017-09-12
WO2011020206A1 (es) 2011-02-24
BR112012003842A2 (pt) 2016-03-22
EP2510916A4 (en) 2016-01-20
DK2510916T3 (en) 2017-07-24
PT2510916T (pt) 2017-07-13
CN102639100A (zh) 2012-08-15
RU2012110038A (ru) 2013-09-27

Similar Documents

Publication Publication Date Title
CL2009001747A1 (es) Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales.
CL2015001694A1 (es) Composicion que comprende un complejo de haluro de zinc tetrabasico-aminoacido o trialquil glicina y cisteina en forma libre o de sal aceptable oralmente o cosmetico; y su uso para eliminar bacterias, reducir la transpiracion y/o el olor corporal, tratar o reducir el acne, limpiar los dientes e inhibir las caries, entre otros.
CY1113449T1 (el) Αντι-ιικες συνθεσεις που περιλαμβανουν γερανιολη και καρβονη
AR094012A1 (es) Composiciones estables con peroxido para el cuidado oral
CL2010000935A1 (es) Compuestos derivados de niacina unida a un acido graso; composicion farmaceutica que los comprende; y su uso para tratar una enfermedad metabolica tal como hipertrigliceridemia, hipercolesterolemia, diabetes tipo 2 y retinopatia diabetica.
PE20130063A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
MX377553B (es) Composicion farmaceutica estable y metodos de uso de la misma.
BR112014009031A2 (pt) formulações de etanercept estabilizadas com íons de metais
PH12013500721A1 (en) Oral care product and methods of use and manufacture thereof
UY32109A (es) Métodos para utilizar composiciones de liberación sostenida de aminopiridina
CR11418A (es) Trans-clomifeno para el sindrome metabolico
MX2012001168A (es) Composiciones para el cuidado bucal que comprenden estaño, potasio y monofluorofosfato.
TW200744617A (en) Agent increasing the production of thioredoxin
ECSP088689A (es) NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS
AR089269A1 (es) Composiciones para el cuidado oral
CL2012002815A1 (es) Composicion para el cuidado bucal que comprende uno o mas compuesto de curcumina y una fuente de iones de zinc; correspondiente a 0.02 a 3% en peso de citrato de zinc; y uso de una fuente de iones de zinc para suprimir la degradacion y/o decoloracion del compuesto de curcumina en una composicion ara el cuidado bucal.
MX2012005689A (es) Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos.
AR075274A1 (es) Agente de tratamiento de semillas y metodo para proteger una planta
AR085042A1 (es) Composiciones de cuidado oral con extracto de magnolia
DOP2011000335A (es) Combinacion antitumoral que comprende ave8062 y sorafenib
AR070593A1 (es) Composiciones efervescentes
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
AR083329A1 (es) Composiciones para el cuidado oral
MX337031B (es) Producto de cuidado oral para el cuidado del esmalte sensible.